GSK, Teva Face Antitrust Class Action Over Lamictal Deal

By Sean McLernon · February 23, 2012, 7:32 PM EST

A drug distributor lodged a putative antitrust class action against GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd. in New Jersey federal court Wednesday, accusing the companies of conspiring to keep a...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

LOUISIANA WHOLESALE DRUG CO., INC. v. SMITHKLINE BEECHAM CORPORATION et al

Case Number

Court

New Jersey

Nature of Suit

Anti-Trust

Date Filed

February 17, 2012

Recent Articles By Sean

January 23, 2015
Health First Can't Dodge Docs' Monopoly Allegations
January 07, 2015
House Locks Down Law Prof. Who Replaced Quinn In ACA Suit
December 18, 2014
Former Rite Aid VP Cops To $15M Kickback Scheme Lies
October 31, 2014
Ebola Nurse Showing No Symptoms Avoids Quarantine
October 31, 2014
CMS Finalizes Rule On Home Health Pay, Fraud Prevention
October 31, 2014
Walgreen Says Gov't Deal Dooms Gift Card FCA Suit
October 24, 2014
FCA Whistleblower Wants Humana Suit Restrictions Lifted
October 24, 2014
Pa. Justices Take Up Medicaid Subcontractor Pay Release Suit
October 17, 2014
Obama Names Ex-O'Melveny Partner Klain As Ebola Czar
October 10, 2014
CareMed Forks Over $10M To Settle FCA Phone Fraud Suit